Late-onset  ||| S:0 E:11 ||| JJ
rheumatoid  ||| S:11 E:22 ||| JJ
arthritis  ||| S:22 E:32 ||| NN
and  ||| S:32 E:36 ||| CC
late-onset  ||| S:36 E:47 ||| JJ
spondyloarthritis  ||| S:47 E:65 ||| NNS
Both  ||| S:65 E:70 ||| DT
rheumatoid  ||| S:70 E:81 ||| JJ
arthritis  ||| S:81 E:91 ||| NN
and  ||| S:91 E:95 ||| CC
spondyloarthritis  ||| S:95 E:113 ||| NNS
may  ||| S:113 E:117 ||| MD
have  ||| S:117 E:122 ||| VB
a  ||| S:122 E:124 ||| DT
late  ||| S:124 E:129 ||| JJ
onset ||| S:129 E:134 ||| NN
.  ||| S:134 E:136 ||| .
Elderly-onset  ||| S:136 E:150 ||| JJ
rheumatoid  ||| S:150 E:161 ||| JJ
arthritis  ||| S:161 E:171 ||| NN
is  ||| S:171 E:174 ||| VBZ
usually  ||| S:174 E:182 ||| RB
defined  ||| S:182 E:190 ||| VBN
as  ||| S:190 E:193 ||| IN
rheumatoid  ||| S:193 E:204 ||| JJ
arthritis  ||| S:204 E:214 ||| NN
with  ||| S:214 E:219 ||| IN
onset  ||| S:219 E:225 ||| NN
at  ||| S:225 E:228 ||| IN
age  ||| S:228 E:232 ||| NN
60  ||| S:232 E:235 ||| CD
or  ||| S:235 E:238 ||| CC
over ||| S:238 E:242 ||| RB
.  ||| S:242 E:244 ||| .
It  ||| S:244 E:247 ||| PRP
appears  ||| S:247 E:255 ||| VBZ
to  ||| S:255 E:258 ||| TO
be  ||| S:258 E:261 ||| VB
a  ||| S:261 E:263 ||| DT
heterogeneous  ||| S:263 E:277 ||| JJ
disease ||| S:277 E:284 ||| NN
,  ||| S:284 E:286 ||| ,
with  ||| S:286 E:291 ||| IN
a  ||| S:291 E:293 ||| DT
seropositive  ||| S:293 E:306 ||| FW
subset  ||| S:306 E:313 ||| FW
resembling  ||| S:313 E:324 ||| FW
adult-onset  ||| S:324 E:336 ||| FW
rheumatoid  ||| S:336 E:347 ||| FW
arthritis ||| S:347 E:356 ||| FW
,  ||| S:356 E:358 ||| ,
and  ||| S:358 E:362 ||| CC
a  ||| S:362 E:364 ||| DT
less  ||| S:364 E:369 ||| RBR
severe  ||| S:369 E:376 ||| JJ
seronegative  ||| S:376 E:389 ||| JJ
subset  ||| S:389 E:396 ||| NN
which  ||| S:396 E:402 ||| WDT
sometimes  ||| S:402 E:412 ||| RB
exhibits  ||| S:412 E:421 ||| JJ
features  ||| S:421 E:430 ||| NNS
overlapping  ||| S:430 E:442 ||| VBG
with  ||| S:442 E:447 ||| IN
those  ||| S:447 E:453 ||| DT
of  ||| S:453 E:456 ||| IN
polymyalgia  ||| S:456 E:468 ||| JJ
rheumatica ||| S:468 E:478 ||| NN
.  ||| S:478 E:480 ||| .
The  ||| S:480 E:484 ||| DT
spondyloarthritis  ||| S:484 E:502 ||| JJ
complex  ||| S:502 E:510 ||| NN
includes  ||| S:510 E:519 ||| VBZ
definite  ||| S:519 E:528 ||| JJ
entities  ||| S:528 E:537 ||| NNS
as  ||| S:537 E:540 ||| IN
well  ||| S:540 E:545 ||| RB
as  ||| S:545 E:548 ||| IN
undifferentiated  ||| S:548 E:565 ||| JJ
forms ||| S:565 E:570 ||| NNS
.  ||| S:570 E:572 ||| .
Each  ||| S:572 E:577 ||| DT
of  ||| S:577 E:580 ||| IN
these  ||| S:580 E:586 ||| DT
may  ||| S:586 E:590 ||| MD
have  ||| S:590 E:595 ||| VB
a  ||| S:595 E:597 ||| DT
late-onset ||| S:597 E:607 ||| JJ
.  ||| S:607 E:609 ||| .
Late-onset  ||| S:609 E:620 ||| JJ
undifferentiated  ||| S:620 E:637 ||| JJ
spondyloarthritis  ||| S:637 E:655 ||| NN
appears  ||| S:655 E:663 ||| VBZ
to  ||| S:663 E:666 ||| TO
be  ||| S:666 E:669 ||| VB
relatively  ||| S:669 E:680 ||| RB
more  ||| S:680 E:685 ||| RBR
frequent  ||| S:685 E:694 ||| JJ
than  ||| S:694 E:699 ||| IN
late-onset  ||| S:699 E:710 ||| JJ
ankylosing  ||| S:710 E:721 ||| JJ
spondylitis ||| S:721 E:732 ||| NN
.  ||| S:732 E:734 ||| .
Its  ||| S:734 E:738 ||| PRP$
clinical  ||| S:738 E:747 ||| JJ
spectrum  ||| S:747 E:756 ||| NN
seems  ||| S:756 E:762 ||| VBZ
to  ||| S:762 E:765 ||| TO
be  ||| S:765 E:768 ||| VB
as  ||| S:768 E:771 ||| IN
broad  ||| S:771 E:777 ||| JJ
as  ||| S:777 E:780 ||| IN
that  ||| S:780 E:785 ||| WDT
observed  ||| S:785 E:794 ||| VBD
in  ||| S:794 E:797 ||| IN
young  ||| S:797 E:803 ||| JJ
and  ||| S:803 E:807 ||| CC
middle-aged  ||| S:807 E:819 ||| JJ
adults  ||| S:819 E:826 ||| NNS
with  ||| S:826 E:831 ||| IN
the  ||| S:831 E:835 ||| DT
exception  ||| S:835 E:845 ||| NN
of  ||| S:845 E:848 ||| IN
distal  ||| S:848 E:855 ||| JJ
inflammatory  ||| S:855 E:868 ||| JJ
swelling  ||| S:868 E:877 ||| NN
with  ||| S:877 E:882 ||| IN
pitting  ||| S:882 E:890 ||| JJ
oedema ||| S:890 E:896 ||| NN
.  ||| S:896 E:898 ||| .
A  ||| S:898 E:900 ||| DT
special  ||| S:900 E:908 ||| JJ
aspect  ||| S:908 E:915 ||| NN
of  ||| S:915 E:918 ||| IN
the  ||| S:918 E:922 ||| DT
differential  ||| S:922 E:935 ||| JJ
diagnosis  ||| S:935 E:945 ||| NN
is  ||| S:945 E:948 ||| VBZ
the  ||| S:948 E:952 ||| DT
discrimination  ||| S:952 E:967 ||| NN
from  ||| S:967 E:972 ||| IN
other  ||| S:972 E:978 ||| JJ
elderly-onset  ||| S:978 E:992 ||| JJ
diseases  ||| S:992 E:1001 ||| NNS
showing  ||| S:1001 E:1009 ||| VBG
the  ||| S:1009 E:1013 ||| DT
inflammatory  ||| S:1013 E:1026 ||| JJ
swelling  ||| S:1026 E:1035 ||| NN
with  ||| S:1035 E:1040 ||| IN
pitting  ||| S:1040 E:1048 ||| JJ
oedema  ||| S:1048 E:1055 ||| NN
over  ||| S:1055 E:1060 ||| IN
the  ||| S:1060 E:1064 ||| DT
dorsum  ||| S:1064 E:1071 ||| NN
of  ||| S:1071 E:1074 ||| IN
feet  ||| S:1074 E:1079 ||| NNS
or  ||| S:1079 E:1082 ||| CC
hands ||| S:1082 E:1087 ||| NNS
.  ||| S:1087 E:1089 ||| .
Psoriatic  ||| S:1089 E:1099 ||| JJ
arthritis  ||| S:1099 E:1109 ||| NN
frequently  ||| S:1109 E:1120 ||| RB
begins  ||| S:1120 E:1127 ||| VBZ
in  ||| S:1127 E:1130 ||| IN
the  ||| S:1130 E:1134 ||| DT
elderly  ||| S:1134 E:1142 ||| JJ
and  ||| S:1142 E:1146 ||| CC
shows  ||| S:1146 E:1152 ||| VBZ
some  ||| S:1152 E:1157 ||| DT
differences  ||| S:1157 E:1169 ||| NNS
from  ||| S:1169 E:1174 ||| IN
the  ||| S:1174 E:1178 ||| DT
younger  ||| S:1178 E:1186 ||| JJR
onset  ||| S:1186 E:1192 ||| NN
disease ||| S:1192 E:1199 ||| NN
.  ||| S:1199 E:1201 ||| .
Regarding  ||| S:1201 E:1211 ||| VBG
the  ||| S:1211 E:1215 ||| DT
management ||| S:1215 E:1225 ||| NN
,  ||| S:1225 E:1227 ||| ,
patients  ||| S:1227 E:1236 ||| NNS
with  ||| S:1236 E:1241 ||| IN
late-onset  ||| S:1241 E:1252 ||| JJ
rheumatoid  ||| S:1252 E:1263 ||| JJ
arthritis  ||| S:1263 E:1273 ||| NN
and  ||| S:1273 E:1277 ||| CC
spondyloarthritis  ||| S:1277 E:1295 ||| NNS
are  ||| S:1295 E:1299 ||| VBP
treated  ||| S:1299 E:1307 ||| VBN
similarly  ||| S:1307 E:1317 ||| RB
to  ||| S:1317 E:1320 ||| TO
younger  ||| S:1320 E:1328 ||| JJR
patients  ||| S:1328 E:1337 ||| NNS
taking  ||| S:1337 E:1344 ||| VBG
into  ||| S:1344 E:1349 ||| IN
account  ||| S:1349 E:1357 ||| NN
age-related  ||| S:1357 E:1369 ||| JJ
changes  ||| S:1369 E:1377 ||| NNS
in  ||| S:1377 E:1380 ||| IN
the  ||| S:1380 E:1384 ||| DT
pharmacokinetics  ||| S:1384 E:1401 ||| NN
and  ||| S:1401 E:1405 ||| CC
pharmacodynamics  ||| S:1405 E:1422 ||| NN
of  ||| S:1422 E:1425 ||| IN
drugs  ||| S:1425 E:1431 ||| NNS
and  ||| S:1431 E:1435 ||| CC
the  ||| S:1435 E:1439 ||| DT
presence  ||| S:1439 E:1448 ||| NN
of  ||| S:1448 E:1451 ||| IN
conditions  ||| S:1451 E:1462 ||| NNS
able  ||| S:1462 E:1467 ||| JJ
to  ||| S:1467 E:1470 ||| TO
reduce  ||| S:1470 E:1477 ||| VB
medication  ||| S:1477 E:1488 ||| JJ
adherence ||| S:1488 E:1497 ||| NN
.  ||| S:1497 E:1499 ||| .
